Darya-Varia Laboratoria Tbk - Asset Resilience Ratio
Darya-Varia Laboratoria Tbk (DVLA) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2024)
This chart shows how Darya-Varia Laboratoria Tbk's Asset Resilience Ratio has changed over time. Check DVLA strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Darya-Varia Laboratoria Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Darya-Varia Laboratoria Tbk.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 0% |
| Short-term Investments | Rp0.00 | 0% |
| Total Liquid Assets | Rp0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Darya-Varia Laboratoria Tbk maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Darya-Varia Laboratoria Tbk Industry Peers by Asset Resilience Ratio
Compare Darya-Varia Laboratoria Tbk's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
JW Pharmaceutical Corp
KO:001067 |
Drug Manufacturers - Specialty & Generic | 8.17% |
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 11.60% |
|
Guilin Sanjin Pharmaceutical Co Ltd
SHE:002275 |
Drug Manufacturers - Specialty & Generic | 14.80% |
|
Fuan Pharmaceutical Group Co
SHE:300194 |
Drug Manufacturers - Specialty & Generic | 1.34% |
|
DRI Healthcare Trust
TO:DHT-U |
Drug Manufacturers - Specialty & Generic | 13.91% |
|
Hainan Shuangcheng Pharmaceut
SHE:002693 |
Drug Manufacturers - Specialty & Generic | 1.03% |
Annual Asset Resilience Ratio for Darya-Varia Laboratoria Tbk (2008–2024)
The table below shows the annual Asset Resilience Ratio data for Darya-Varia Laboratoria Tbk.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.00% | Rp0.00 ≈ $0.00 |
Rp2.16 Trillion ≈ $126.66 Million |
-- |
| 2023-12-31 | 0.64% | Rp13.00 Billion ≈ $761.75K |
Rp2.04 Trillion ≈ $119.66 Million |
+2.75pp |
| 2022-12-31 | -2.11% | Rp-42.43 Billion ≈ $-2.49 Million |
Rp2.01 Trillion ≈ $117.73 Million |
+0.05pp |
| 2021-12-31 | -2.16% | Rp-45.04 Billion ≈ $-2.64 Million |
Rp2.09 Trillion ≈ $122.23 Million |
-2.79pp |
| 2020-12-31 | 0.63% | Rp12.59 Billion ≈ $737.60K |
Rp1.99 Trillion ≈ $116.41 Million |
+4.82pp |
| 2019-12-31 | -4.19% | Rp-76.61 Billion ≈ $-4.49 Million |
Rp1.83 Trillion ≈ $107.23 Million |
-8.88pp |
| 2018-12-31 | 4.69% | Rp79.00 Billion ≈ $4.63 Million |
Rp1.68 Trillion ≈ $98.61 Million |
-14.08pp |
| 2017-12-31 | 18.77% | Rp308.00 Billion ≈ $18.05 Million |
Rp1.64 Trillion ≈ $96.15 Million |
+18.27pp |
| 2016-12-31 | 0.50% | Rp7.71 Billion ≈ $451.51K |
Rp1.53 Trillion ≈ $89.73 Million |
+0.04pp |
| 2015-12-31 | 0.47% | Rp6.43 Billion ≈ $376.59K |
Rp1.38 Trillion ≈ $80.64 Million |
+0.06pp |
| 2014-12-31 | 0.41% | Rp5.08 Billion ≈ $297.92K |
Rp1.24 Trillion ≈ $72.44 Million |
-0.14pp |
| 2013-12-31 | 0.55% | Rp6.50 Billion ≈ $381.07K |
Rp1.19 Trillion ≈ $69.73 Million |
+0.27pp |
| 2012-12-31 | 0.28% | Rp3.01 Billion ≈ $176.36K |
Rp1.07 Trillion ≈ $62.97 Million |
+0.03pp |
| 2009-12-31 | 0.25% | Rp1.98 Billion ≈ $115.90K |
Rp783.61 Billion ≈ $45.92 Million |
+0.08pp |
| 2008-12-31 | 0.17% | Rp1.08 Billion ≈ $63.51K |
Rp637.66 Billion ≈ $37.36 Million |
-- |
About Darya-Varia Laboratoria Tbk
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women hea… Read more